In our microarray analysis, we identified potential downstream targets of MELK, including STAT5 and NFKB target genes, as well as genes involved in tumor progression and metastasis (i.e., EMT, angiogenesis, hypoxia, and apical junction). This evidence concerns the gene NFKB1 and neoplasm.